GRFS
Price
$10.78
Change
+$0.13 (+1.22%)
Updated
Aug 8, 10:37 AM (EDT)
Capitalization
5.48B
90 days until earnings call
MIRA
Price
$1.36
Change
-$0.01 (-0.73%)
Updated
Aug 8, 10:45 AM (EDT)
Capitalization
16.26M
26 days until earnings call
Interact to see
Advertisement

GRFS vs MIRA

Header iconGRFS vs MIRA Comparison
Open Charts GRFS vs MIRABanner chart's image
Grifols SA
Price$10.78
Change+$0.13 (+1.22%)
Volume$200
Capitalization5.48B
MIRA Pharmaceuticals
Price$1.36
Change-$0.01 (-0.73%)
Volume$500
Capitalization16.26M
GRFS vs MIRA Comparison Chart in %
Loading...
GRFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRFS vs. MIRA commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRFS is a Buy and MIRA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (GRFS: $10.65 vs. MIRA: $1.37)
Brand notoriety: GRFS and MIRA are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GRFS: 109% vs. MIRA: 22%
Market capitalization -- GRFS: $5.48B vs. MIRA: $16.26M
GRFS [@Pharmaceuticals: Major] is valued at $5.48B. MIRA’s [@Pharmaceuticals: Major] market capitalization is $16.26M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRFS’s FA Score shows that 1 FA rating(s) are green whileMIRA’s FA Score has 0 green FA rating(s).

  • GRFS’s FA Score: 1 green, 4 red.
  • MIRA’s FA Score: 0 green, 5 red.
According to our system of comparison, GRFS is a better buy in the long-term than MIRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRFS’s TA Score shows that 4 TA indicator(s) are bullish while MIRA’s TA Score has 4 bullish TA indicator(s).

  • GRFS’s TA Score: 4 bullish, 4 bearish.
  • MIRA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GRFS is a better buy in the short-term than MIRA.

Price Growth

GRFS (@Pharmaceuticals: Major) experienced а -0.47% price change this week, while MIRA (@Pharmaceuticals: Major) price change was -16.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.43%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was +13.43%.

Reported Earning Dates

GRFS is expected to report earnings on Nov 06, 2025.

MIRA is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.43% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GRFS($5.48B) has a higher market cap than MIRA($16.3M). GRFS YTD gains are higher at: 43.145 vs. MIRA (20.175). GRFS has higher annual earnings (EBITDA): 640M vs. MIRA (-6.82M). GRFS has more cash in the bank: 544M vs. MIRA (5.87M). MIRA has less debt than GRFS: MIRA (109K) vs GRFS (11.1B). GRFS has higher revenues than MIRA: GRFS (6.54B) vs MIRA (0).
GRFSMIRAGRFS / MIRA
Capitalization5.48B16.3M33,595%
EBITDA640M-6.82M-9,388%
Gain YTD43.14520.175214%
P/E Ratio68.68N/A-
Revenue6.54B0-
Total Cash544M5.87M9,271%
Total Debt11.1B109K10,183,486%
FUNDAMENTALS RATINGS
GRFS: Fundamental Ratings
GRFS
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
82
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRFSMIRA
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 5 days ago
63%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 10 days ago
73%
Bullish Trend 17 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GRFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIEQX18.78N/A
N/A
T. Rowe Price International Eq Index
MGGIX39.62N/A
N/A
Morgan Stanley Inst Global Opp I
RGRYX36.70N/A
N/A
Victory RS Growth Y
VWNAX83.09N/A
N/A
Vanguard Windsor™ II Admiral™
ETAEX13.60N/A
N/A
Eventide Exponential Technologies A

GRFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRFS has been closely correlated with GIKLY. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GRFS jumps, then GIKLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRFS
1D Price
Change %
GRFS100%
+0.19%
GIKLY - GRFS
68%
Closely correlated
N/A
GIFOF - GRFS
37%
Loosely correlated
N/A
PFE - GRFS
28%
Poorly correlated
+1.25%
BIIB - GRFS
28%
Poorly correlated
-3.87%
GILD - GRFS
28%
Poorly correlated
-1.94%
More

MIRA and

Correlation & Price change

A.I.dvisor tells us that MIRA and OGN have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIRA and OGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRA
1D Price
Change %
MIRA100%
-4.20%
OGN - MIRA
13%
Poorly correlated
+4.47%
GRFS - MIRA
9%
Poorly correlated
+0.19%
RHHBF - MIRA
8%
Poorly correlated
N/A
RHHVF - MIRA
8%
Poorly correlated
+0.37%
SNYNF - MIRA
7%
Poorly correlated
+1.82%
More